The Centers for Medicare and Medicaid Services (CMS) has released an interim final rule addressing COVID-19 vaccine coverage.
QualChoice is closely following advancements in the prevention and treatment of COVID-19, including vaccinations. As a healthcare provider, you will play an integral role as COVID-19 vaccines become available. We want to update you on important new information about vaccine coverage.
To prepare for vaccine administration, the CMS has begun to publish guidance for providers. Similar to other COVID-19 services, the vaccines will be offered at no cost to your patients. In addition:
- QualChoice will configure its systems to properly adjudicate COVID-19 vaccine-related claims, both for the vaccine and its administration.
- Member liability will be $0.
- Non-participating provider pre-auth requirements will be waived.
- Provider reimbursement rates and emergency use authorizations (EUA) are all still pending and we will update you as that information becomes available.
The American Medical Association (AMA) has published updates to the Current Procedural Terminology (CPT®) code set that includes new vaccine-specific codes to report immunizations for the novel coronavirus (SARS-CoV-2). The code set will continue to be updated as additional vaccines receive EUA approval by the U.S. Food & Drug Administration (FDA).
The following codes have been published as of November 10, 2020. However, they will not be billable until the specific vaccine receives official EUA approval.|
Code |
CPT Short Descriptor |
Labeler Name |
Vaccine/Procedure Name |
|
91300 |
SARSCOV2 VAC 30MCG/0.3ML IM |
Pfizer |
Pfizer-Biotech COVID-19 Vaccine |
|
0001A |
ADM SARSCOV2 VAC 30MCG/0.3ML 1ST |
Pfizer |
Pfizer-Biotech COVID-19 Vaccine Administration – First Dose |
|
0002A |
ADM SARSCOV2 VAC 30MCG/0.3ML 2ND |
Pfizer |
Pfizer-Biotech COVID-19 Vaccine Administration – Second Dose |
|
91301 |
SARSCOV2 VAC 100MCG/0.5ML IM |
Moderna |
Moderna COVID-19 Vaccine |
|
0011A |
ADM SARSCOV2 VAC 100MCG/0.5ML 1ST |
Moderna |
Moderna COVID-19 Vaccine Administration – First Dose |
|
0012A |
ADM SARSCOV2 VAC 100MCG/0.5ML 2ND |
Moderna |
Moderna COVID-19 Vaccine Administration – Second Dose |
Additionally, CMS has also published a set of toolkits to help providers prepare to swiftly administer the vaccine once it is available. If you have any further questions about this upcoming vaccine or the COVID-19 services QualChoice covers, please contact Provider Services at 501.228.7111, ext. 7004.
